AIM at Melanoma Foundation
 | |
| Founded | 2008 |
|---|---|
| Founder | Valerie Guild Jean Schlipmann |
| Location |
|
Key people | Valerie Guild Jean Schlipmann |
| Website | http://AIMatMelanoma.org |
The AIM at Melanoma Foundation (AIM) is a nonprofit organization focused on melanoma research.[1]
AIM was created as a collaboration between the Charlie Guild Foundation and James A. Schlipmann Melanoma Cancer Foundation.[2]
Activities[edit]
AIM is a partner of the Society for Immunotherapy of Cancer.[3]
Sponsors[edit]
In the first quarter of 2021, the foundation received a $10,000 grant from Pfizer for a project titled “From the Clinic to the Living Room”.[4] Additional industry sponsors include:[5]
References[edit]
- ^ "About". Aim at Melanoma. Retrieved 2011-12-10.
- ^ "International Melanoma Tissue Bank in the Works". Cure Today. Retrieved 2023-02-24.
- ^ "Cancer Immunotherapy Partnerships and Collaborations". Society for Immunotherapy of Cancer. Archived from the original on 2023-05-10. Retrieved 2023-05-10.
- ^ "US Medical, Scientific, Patient and Civic Organization Funding Report: Q1-Q2 2021" (PDF). Pfizer. 2021-09-27. Archived (PDF) from the original on 2023-05-03. Retrieved 2023-05-10.
- ^ "Our Industry Partners". AIM at Melanoma Foundation. Archived from the original on 2023-05-10. Retrieved 2023-05-11.
